SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-19-025895
Filing Date
2019-12-11
Accepted
2019-12-11 16:38:47
Documents
6
Period of Report
2019-12-10

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k121019_therapixbio.htm 6-K 17745
2 NOTICE OF ANNUAL AND SPECIAL GENERAL MEETING OF SHAREHOLDERS, PROXY STATEMENT AN f6k121019ex99-1_therapixbio.htm EX-99.1 920684
3 VOTING INSTRUCTION FORM FOR HOLDERS OF AMERICAN DEPOSITARY SHARES f6k121019ex99-2_therapixbio.htm EX-99.2 1756
4 GRAPHIC image_001.jpg GRAPHIC 12451
5 GRAPHIC ex99-2_001.jpg GRAPHIC 1324127
6 GRAPHIC ex99-2_002.jpg GRAPHIC 2872385
  Complete submission text file 0001213900-19-025895.txt   6739073
Mailing Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047
Business Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047 972-3-6167055
Therapix Biosciences Ltd. (Filer) CIK: 0001611746 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38041 | Film No.: 191280145
SIC: 2834 Pharmaceutical Preparations